Trends-in-Medicine
	Lynne Peterson, Senior Writer Trends-in-Medicine has no financial connections with any pharmaceutical or medical device company. The information and opinions expressed have been compiled or arrived at from sources believed to be reliable and in good faith, but no liability is assumed for information contained in this newsletter. Copyright©  2002 No articles may be reproduced without written permission of the publisher. Return Home
					March 2002 issues (click links below for full story) Niacin Summary: Niaspan has increased with the increased attention on HDL levels, but the outlook is for that growth to slow. Doctors are starting to prescribe Advicor, but most are taking a cautious approach to it, and it is likely to cannibalize Niaspan sales rather than expand the market – unless it helps make primary care doctors more comfortable with niacin. Arterial Closure Devices Summary: There appears to be no growth in the arterial closure device market. Cardiac cath labs said usage has been flat for the past six months, and the outlook is for that trend to continue. Perclose remains the slight favorite, with the rest of the market split fairly closely among AngioSeal, VasoSeal and Duett, though a few labs are eschewing most if not all of these in favor of the Syvek patch.
For subscription information contact Stephen Snyder, Publisher 1879 Avenida Dracaena, Jensen Beach, FL, 34957, 772-334-7409, Fax 772-334-0856 Email webmaster about site: snyderk577@aol.com